{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:36:12Z","timestamp":1793262972794,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,19]],"date-time":"2027-09-19T00:00:00Z","timestamp":1821312000000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jiac.2026.103082","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:23:13Z","timestamp":1789662193000},"page":"103082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cefazolin versus cefmetazole for surgical antibiotic prophylaxis in total hip arthroplasty: Impact on postoperative infection rates"],"prefix":"10.1016","volume":"32","author":[{"given":"Daisuke","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamon","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musashi","family":"Ima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iyobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Fujimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rin","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Demura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiac.2026.103082_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s13018-022-03355-3","article-title":"Systematic review: preoperative psychological factors and total hip arthroplasty outcomes","volume":"17","author":"O'Connor","year":"2022","journal-title":"J Orthop Surg Res"},{"issue":"6S","key":"10.1016\/j.jiac.2026.103082_bib2","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.arth.2020.02.030","article-title":"Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030","volume":"35","author":"Schwartz","year":"2020","journal-title":"J Arthroplast"},{"key":"10.1016\/j.jiac.2026.103082_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J Arthroplast"},{"issue":"1S1","key":"10.1016\/j.jiac.2026.103082_bib5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.arth.2025.10.087","article-title":"2025 ICM: antibiotic prophylaxis","volume":"41","author":"Shahi","year":"2025","journal-title":"J Arthroplast"},{"issue":"6_Supple_B","key":"10.1016\/j.jiac.2026.103082_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1407.R1","article-title":"2019 John Charnley Award: increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis","volume":"101-B","author":"Wyles","year":"2019","journal-title":"Bone Joint J"},{"issue":"10","key":"10.1016\/j.jiac.2026.103082_bib7","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.arth.2025.04.079","article-title":"Cefazolin is associated with a lower periprosthetic joint infection risk than alternative antibiotic regimens following total hip arthroplasty","volume":"40","author":"Carter","year":"2025","journal-title":"J Arthroplast"},{"issue":"14","key":"10.1016\/j.jiac.2026.103082_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.artd.2022.02.019","article-title":"Increased rate of early periprosthetic joint infection in total hip arthroplasty with the use of alternatives to Cefazolin despite additional gram-negative coverage","author":"Ortiz","year":"2022","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.jiac.2026.103082_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/cid\/ciaa216","article-title":"Critical national shortage of cefazolin in Japan: management strategies","volume":"71","author":"Honda","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103082_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jiph.2023.01.021","article-title":"Impact of the cefazolin shortage on the selection and cost of parenteral antibiotics during the supply disruption period in Japan: a controlled interrupted time series analysis","volume":"16","author":"Nagano","year":"2023","journal-title":"J Infect Public Health"},{"issue":"4S","key":"10.1016\/j.jiac.2026.103082_bib11","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jiac.2026.103082_bib12","series-title":"NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infection in the acute care setting","year":"2013"},{"key":"10.1016\/j.jiac.2026.103082_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jiac.2026.103082_bib14","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11999-011-2111-8","article-title":"Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis?","volume":"469","author":"Yamada","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.jiac.2026.103082_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/j.1875-9114.1991.tb03592.x","article-title":"Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials","volume":"11","author":"Schentag","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2026.103082_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.artd.2022.02.019","article-title":"Increased rate of early periprosthetic joint infection in total hip arthroplasty with the use of alternatives to cefazolin despite additional gram-negative coverage","volume":"14","author":"Ortiz","year":"2022","journal-title":"Arthroplasty Today"},{"issue":"6","key":"10.1016\/j.jiac.2026.103082_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jos.2025.03.010","article-title":"Antimicrobial prophylaxis with ampicillin\/sulbactam versus cefazolin for orthopedic implant-related surgical site infections: a retrospective cohort studyJ","volume":"30","author":"Hatano","year":"2025","journal-title":"Orthop Sci"},{"issue":"3","key":"10.1016\/j.jiac.2026.103082_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2025.112215","article-title":"Cefazolin vs. alternative beta-lactams for prophylaxis in lower extremity fracture surgery: a target trial emulation","volume":"56","author":"Yoshiyama","year":"2025","journal-title":"Injury"},{"issue":"7 Supple B","key":"10.1016\/j.jiac.2026.103082_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1302\/0301-620X.103B7.BJJ-2020-2292.R1","article-title":"Outcomes of simultaneous bilateral total hip arthroplasty for 256 selected patients in a single surgeon's practice","volume":"103-B","author":"Inoue","year":"2021","journal-title":"Bone Joint J"},{"issue":"1","key":"10.1016\/j.jiac.2026.103082_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s13018-022-03281-4","article-title":"Simultaneous versus staged bilateral total hip arthroplasty: a systematic review and meta-analysis","volume":"17","author":"Ramezani","year":"2022","journal-title":"J Orthop Surg Res"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:13:00Z","timestamp":1793261580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1341321X26001807"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103082","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefazolin versus cefmetazole for surgical antibiotic prophylaxis in total hip arthroplasty: Impact on postoperative infection rates","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103082"}}